Platelet-Rich Plasma (PRP) in Gynecology: Scientific Foundations and Clinical Evolution
Gynecology has witnessed a significant transformation with the integration of regenerative medicine. Among the most promising modalities, Platelet-Rich Plasma (PRP) has emerged as a scientifically grounded, autologous treatment that supports tissue repair, vascular regeneration, and functional restoration in female reproductive health.
PRP in gynecology is increasingly adopted due to its safety profile, biological compatibility, and growing clinical evidence supporting its effectiveness across multiple indications.
PRP is derived from the patient’s own blood through controlled centrifugation, resulting in a plasma fraction enriched with platelets and growth factors. These bioactive molecules—such as PDGF, TGF-β, VEGF, and EGF—play a central role in cellular proliferation, angiogenesis, and extracellular matrix remodeling.
In gynecological tissues, PRP enhances microcirculation, stimulates fibroblast activity, and promotes epithelial regeneration without introducing synthetic or hormonal agents.
Clinical Applications in Gynecology
PRP has demonstrated utility across a wide range of gynecological indications, including:
Vaginal tissue regeneration Post-surgical tissue healing Menopausal tissue support Postpartum recovery Regenerative gynecology protocols
Its versatility allows clinicians to tailor treatments based on patient needs while maintaining a high margin of safety.
Safety and Standardization
As an autologous therapy, PRP significantly reduces the risk of allergic reactions or immune complications. When prepared using CE Marked – Class IIb PRP systems, treatment outcomes become more consistent and clinically reliable.
Globally, PRP has been used in more than 4,000,000 procedures, reinforcing its acceptance and clinical maturity.
Conclusion
PRP in gynecology represents a paradigm shift toward biologically driven, patient-centered care. With expanding research and standardized medical devices, PRP continues to redefine the future of women’s regenerative health.
